Clinical trial
Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1…
NCT00106379 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00106379 |
|---|---|
| Title | Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients |
| Official title | A Phase 4, Single-Arm Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Tenofovir Disoproxil Fumarate in Combination With Emtricitabine in HIV-1 Infected Patients Experiencing Various Degrees of Renal Impairment |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Truvada (tenofovir DF + emtricitabine), Emtriva (emtricitabine), Viread (tenofovir DF) |
| Enrollment | 52 |
| Start date | Oct 1, 2004 |
| Completion | Jan 1, 2007 |
| First posted | Mar 24, 2005 |
| Last update posted | Feb 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: